Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
Ambu A/S is a Danish company operating in the medical device industry, focusing on the development and marketing of products for hospitals and healthcare providers. The company specializes in anesthesiology, patient monitoring and diagnostics, and emergency care solutions. Some of Ambu's key products include single-use endoscopes, resuscitators, and electrodes for patient monitoring. Founded in 1937, Ambu is headquartered in Ballerup, Denmark, and serves a global market with a significant presence in Europe, North America, and Asia. The company is known for its strategic emphasis on innovation in single-use devices, which helps reduce the risk of cross-contamination and improves healthcare efficiency.
View stock
VS
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
View stock

Stock highlights

Stock comparison highlights
Stock name
Ambu A/SEli Lilly
Last price
kr 81.50$1,417.54
Currency
DKK
USD
kr 21B$1.3T
42.4646.01
kr 1.92$30.81
1.390.45
kr 0.41$6.69
0.50%0.49%
Sector
HealthHealth
Employees
5,20050,000
Ticker
DKr AMBU B$LLY
Primary listing
CSENYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in DKrAMBU B or $LLY on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.